Aprea Therapeutics Inc (APRE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

535 BOYLSTON STREET BOSTON, MA 02116

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Aprea Therapeutics serves customers in the United States and Sweden.

Data as of 2020-07-04
Market Cap770.607 Million Shares Outstanding21.055 Million Avg 30-day Volume242.822 Thousand
P/E Ratio Dividend Yield EPS-5.04
Price/Sales Price cash flow ratio Price free cash flow ratio-33.4
Book Value5.38 Price to Tangible Book7.22 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low53.11 / 15.1 Stddev

Are you looking for this stock instead?

View SEC Filings from APRE instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 50 18 (1.18%)
Aggregate 13F shares on 03/31/2020: 13.444 Million 7.015 Million
Aggregate 13F shares on 12/31/2019: 12.932 Million 6.081 Million
Percent change: 3.96% 15.36%
Funds creating new positions: 14 8
Funds Adding to an existing position: 19 8
Funds closing out their position: 4 1
Funds reducing their position: 10 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding APRE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APRE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.3 Million total shares from 13 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HENNEMAN JOHN B III

  • Director
0 2020-07-01 1

ROCKLAGE SCOTT M

0 2020-06-30 4

SEIZINGER BERND R.

0 2020-06-30 1

HEPPLE JONATHAN

0 2020-06-30 1

CHRISTENSON JOHAN

  • Director
3,807,247 2020-06-30 1

VERSANT VANTAGE I, L.P.

VERSANT VANTAGE I GP, L.P.

VERSANT VANTAGE I GP-GP, LLC

  • 10% Owner
16,084,065 2020-06-23 1

5AM VENTURES IV, L.P.

5AM CO-INVESTORS IV, L.P.

5AM PARTNERS IV, LLC

DIEKMAN JOHN D

SCHWAB ANDREW J.

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

PARMAR KUSH

  • 10% Owner
2,212,654 2020-06-16 2

SCHADE CHRISTIAN S

  • Director
42,174 2020-05-13 1

KDEV INVESTMENTS AB

KAROLINSKA DEVELOPMENT AB

KCIF CO-INVESTMENT FUND KB

  • 10% Owner
2,234,289 2020-04-13 1

VERSANT V LUXCO S.A R.L.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

VERSANT VENTURES V, LLC

VERSANT VENTURES V (CANADA), L.P.

  • 10% Owner
0 2020-04-09 1

KORBEL GREGORY ALAN VP OF BUSINESS DEV'T

  • Officer
0 2020-03-24 1

ATTAR EYAL C. SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-24 1

ABRAHMSEN LARS B. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-03-24 1

COIANTE SCOTT M SVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-24 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HEPPLE JONATHAN

2020-06-30 A 5,600 a 5,600 0.00 direct

ROCKLAGE SCOTT M

2020-06-30 A 5,600 a 5,600 0.00 direct

SEIZINGER BERND R.

2020-06-30 A 5,600 a 5,600 0.00 direct

CHRISTENSON JOHAN

2020-06-30 A 5,600 a 5,600 0.00 direct

HENNEMAN JOHN B III

2020-06-30 A 5,600 a 5,600 0.00 direct

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-06-16 S 115,357 $33.30 d 1,823,192 2,212,654.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-06-16 S 19,836 $33.30 d 313,497 2,212,654.00 indirect

ROCKLAGE SCOTT M - Director - > 10% Owner see footnotes

2020-06-16 S 4,807 $33.30 d 75,965 1,899,157.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-06-16 S 4,807 $33.30 d 75,965 2,212,654.00 indirect

ROCKLAGE SCOTT M - Director - > 10% Owner see footnotes

2020-06-16 S 115,357 $33.30 d 1,823,192 1,899,157.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-06-11 S 9,800 $28.75 d 80,772 2,352,654.00 indirect

ROCKLAGE SCOTT M - Director - > 10% Owner see footnotes

2020-06-11 S 235,200 $28.75 d 1,938,549 2,019,321.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-06-11 S 235,200 $28.75 d 1,938,549 2,352,654.00 indirect

ROCKLAGE SCOTT M - Director - > 10% Owner see footnotes

2020-06-11 S 9,800 $28.75 d 80,772 2,019,321.00 indirect

ROCKLAGE SCOTT M - Director see footnotes

2020-05-19 S 10,200 $35.15 d 90,572 2,264,320.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-05-19 S 10,200 $35.15 d 90,572 2,597,653.00 indirect

ROCKLAGE SCOTT M - Director see footnotes

2020-05-19 S 244,800 $35.15 d 2,173,748 2,264,320.00 indirect

5AM VENTURES IV, L.P. - > 10% Owner see footnotes

5AM CO-INVESTORS IV, L.P. - > 10% Owner see footnotes

5AM PARTNERS IV, LLC - > 10% Owner see footnotes

DIEKMAN JOHN D - > 10% Owner see footnotes

SCHWAB ANDREW J. - > 10% Owner see footnotes

5AM OPPORTUNITIES I, L.P. - > 10% Owner see footnotes

5AM OPPORTUNITIES I (GP), LLC - > 10% Owner see footnotes

PARMAR KUSH - > 10% Owner see footnotes

2020-05-19 S 244,800 $35.15 d 2,173,748 2,597,653.00 indirect

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 773,805 d 1,437,132 0.00 direct

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

2020-05-18 J 1,734 a 1,734 216,669.00 indirect

VERSANT VANTAGE I, L.P. - > 10% Owner

VERSANT VANTAGE I GP, L.P. - > 10% Owner

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner

2020-05-18 J 116,664 d 216,669 216,669.00 direct

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 16,428 d 0 0.00 direct

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 25,794 d 47,823 0.00 direct

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

2020-05-18 J 1,750 d 0 216,669.00 indirect

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 1,178 d 0 0.00 direct

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 16,428 a 16,428 0.00 direct

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 23,275 d 43,231 0.00 direct

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

2020-05-18 J 1,734 d 0 216,669.00 indirect

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

2020-05-18 J 1,750 a 1,750 216,669.00 indirect

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 1,178 a 1,178 0.00 direct

VERSANT V LUXCO S.A R.L. - > 10% Owner

VERSANT VENTURE CAPITAL V, L.P. - > 10% Owner

VERSANT AFFILIATES FUND V, L.P. - > 10% Owner

VERSANT OPHTHALMIC AFFILIATES I, L.P. - > 10% Owner

VERSANT VENTURE CAPITAL V (CANADA), LP - > 10% Owner

VERSANT VENTURES V, LLC - > 10% Owner

VERSANT VENTURES V (CANADA), L.P. - > 10% Owner

2020-05-18 J 58,889 d 109,374 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments